Editor: Atta-ur-Rahman

Frontiers in Clinical Drug Research - HIV

Volume 2

eBook: US $100 Special Offer (PDF + Printed Copy): US $169
Printed Copy: US $119
Library License: US $400
ISSN: 2468-0397 (Print)
ISSN: 2352-5916 (Online)
ISBN: 978-1-68108-202-8 (Print)
ISBN: 978-1-68108-201-1 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810820111150201

Introduction

Frontiers in Clinical Drug Research – HIV Frontiers in Clinical Drug Research – HIV is an eBook series that brings updated reviews to readers interested in learning about advances in the development of pharmaceutical agents for the treatment of acquired immune deficiency syndrome (AIDS) and other disorders associated with human immunodeficiency virus (HIV) infection. The scope of the eBook series covers a range of topics including the medicinal chemistry and pharmacology of natural and synthetic drugs employed in the treatment of AIDS (including HAART) and resulting complications, and the virology and immunological study of HIV and related viruses. Frontiers in Clinical Drug Research – HIV is a valuable resource for pharmaceutical scientists, clinicians and postgraduate students seeking updated and critically important information for developing clinical trials and devising research plans in HIV/AIDS research.

The second volume of this series features 5 chapters that cover a variety of topics including:

- HIV-1 Integrase Inhibitors

- HIV in vaginal mucosa

- Long-Acting Antiretroviral Formulations

-The world of people living with HIV/AIDS

Indexed in: Book Citation Index, Science Edition, BIOSIS Previews, Scopus, EMBASE, EBSCO.

Contributors

Editor(s):
Atta-ur-Rahman
Kings College
University of Cambridge
Cambridge
UK




Contributor(s):
Adolphe Ndarabu
Centre Hospitalier Monkole
4804 Ngafani street, Masanga-mbila, Mont-Ngafula, Kinshasa 817 Kinshasa XI
Democratic Republic of Congo


Bhekumusa Wellington Lukhele
Department of Global Health and Socio-epidemiology
Kyoto University School of Public Health
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501
Japan


Christina El-Saaidi
Department of Global Health and Socio-epidemiology
Kyoto University School of Public Health
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501
Japan


Daniela Dastros-Pitei
Mundipharma Research International R&D
Cambridge
UK


Diana Gabriela Iacob
Carol Davila University of Medicine and Pharmacy
Bucharest
Romania


John A. Moss
Department of Chemistry
Oak Crest Institute of Science
Pasadena
California
United States of America


Jucimary Vieira dos Santos
Faculty of Medicine
Rio Grande do Norte State University
Mossoró, 59607-360
Brazil


Marc M. Baum
Department of Chemistry
Oak Crest Institute of Science
Pasadena
California
United States of America


Maria Eugénia Soares Rodrigues Tavares Pina
Center for Chemical Processes Engineering and Forest Products, (CIEPQPF)
Department of Chemical Engineering, Faculty of Sciences and Technology, Faculty of Pharmacy
University of Coimbra
3000-548, Coimbra
Portugal


Masahiro Kihara
Department of Global Health and Socio-epidemiology
Kyoto University School of Public Health
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501
Japan


Masako Ono-Kihara
Department of Global Health and Socio-epidemiology
Kyoto University School of Public Health
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501
Japan


Mitchell D. Feldman
Department of Medicine
University of California San Francisco
1545 Divisadero, Suite 315
Sans Francisco
CA 94143-0320
USA


Patou Masika Musumari
Department of Global Health and Socio-epidemiology
Kyoto University School of Public Health
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501
Japan


Richard B. Pyles
Department of Pediatrics
University of Texas Medical Branch
Galveston
Texas
United States of America
/
Department of Microbiology and Immunology
University of Texas Medical Branch
Galveston
Texas
United States of America


S. Pilar Suguimoto
Department of Global Health and Socio-epidemiology
Kyoto University School of Public Health
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501
Japan


Shengxi Chen
Center for BioEnergetics
Biodesign Institute, Arizona State University
Tempe
Arizona, 85287
USA


Simona Alexandra Iacob
The National Institute of Infectious Diseases "Matei Bals"
Bucharest
Romania


Teeranee Techasrivichien
Department of Global Health and Socio-epidemiology
Kyoto University School of Public Health
Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501
Japan




RELATED BOOKS

.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.
.COVID-19: Origin, Impact and Management (Part 1).